In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation (Q35862318)

10 August 2017

In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation (English)

1 reference

10 August 2017

1

Eui Kyu Chie

1 reference

10 August 2017

Jin Hee Shin

2

1 reference

10 August 2017

Jin Ho Kim

3

1 reference

10 August 2017

Hak Jae Kim

4

1 reference

10 August 2017

In Ah Kim

5

1 reference

10 August 2017

Il Han Kim

6

1 reference

10 August 2017

24 November 2014

1 reference

Cancer Research and Treatment

10 August 2017

1 reference

10 August 2017

47

1 reference

10 August 2017

3

1 reference

10 August 2017

527-533

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

10 August 2017

start time

24 November 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Radiosensitizing potential of epigenetic anticancer drugs.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Inhibition of histone deacetylation: a strategy for tumor radiosensitization

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Epigenetics provides a new generation of oncogenes and tumour-suppressor genes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Histone deacetylase inhibitors are potent radiation protectants

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Valproic acid for the treatment of pediatric malignant glioma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

HDAC inhibition radiosensitizes human normal tissue cells and reduces DNA Double-Strand Break repair capacity.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

The epigenetic modifier, valproic acid, enhances radiation sensitivity

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4506108

Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25600060

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4143/CRT.2014.026

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

25600060

1 reference